160 related articles for article (PubMed ID: 30959951)
1. Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors.
Pozzi C; Ferrari S; Luciani R; Costi MP; Mangani S
Molecules; 2019 Apr; 24(7):. PubMed ID: 30959951
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Destabilization of the Human Thymidylate Synthase (hTS) Dimeric Structure Induced by the Interface Mutation Q62R.
Pozzi C; Lopresti L; Santucci M; Costi MP; Mangani S
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30987202
[TBL] [Abstract][Full Text] [Related]
3. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
Chen D; Jansson A; Sim D; Larsson A; Nordlund P
J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
[TBL] [Abstract][Full Text] [Related]
4. Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.
Salo-Ahen OM; Tochowicz A; Pozzi C; Cardinale D; Ferrari S; Boum Y; Mangani S; Stroud RM; Saxena P; Myllykallio H; Costi MP; Ponterini G; Wade RC
J Med Chem; 2015 Apr; 58(8):3572-81. PubMed ID: 25798950
[TBL] [Abstract][Full Text] [Related]
5. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.
Deschamps P; Réty S; Bareille J; Leulliot N
Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):336-341. PubMed ID: 28580921
[TBL] [Abstract][Full Text] [Related]
8. Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology.
Ponterini G; Martello A; Pavesi G; Lauriola A; Luciani R; Santucci M; Pelà M; Gozzi G; Pacifico S; Guerrini R; Marverti G; Costi MP; D'Arca D
Sci Rep; 2016 Jun; 6():27198. PubMed ID: 27250901
[TBL] [Abstract][Full Text] [Related]
9. Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.
Tochowicz A; Santucci M; Saxena P; Guaitoli G; Trande M; Finer-Moore J; Stroud RM; Costi MP
J Med Chem; 2015 Jan; 58(2):1012-8. PubMed ID: 25427005
[TBL] [Abstract][Full Text] [Related]
10. The active-inactive transition of human thymidylate synthase: targeted molecular dynamics simulations.
Salo-Ahen OM; Wade RC
Proteins; 2011 Oct; 79(10):2886-99. PubMed ID: 21905113
[TBL] [Abstract][Full Text] [Related]
11. Structural Comparison of
Pozzi C; Ferrari S; Luciani R; Tassone G; Costi MP; Mangani S
Molecules; 2019 Mar; 24(7):. PubMed ID: 30935102
[TBL] [Abstract][Full Text] [Related]
12. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase.
Berger SH; Berger FG; Lebioda L
Biochim Biophys Acta; 2004 Jan; 1696(1):15-22. PubMed ID: 14726200
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding.
Cardinale D; Salo-Ahen OM; Guaitoli G; Ferrari S; Venturelli A; Franchini S; Battini R; Ponterini G; Wade RC; Costi MP
Protein Eng Des Sel; 2010 Feb; 23(2):81-9. PubMed ID: 19955218
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
Cardinale D; Guaitoli G; Tondi D; Luciani R; Henrich S; Salo-Ahen OM; Ferrari S; Marverti G; Guerrieri D; Ligabue A; Frassineti C; Pozzi C; Mangani S; Fessas D; Guerrini R; Ponterini G; Wade RC; Costi MP
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E542-9. PubMed ID: 21795601
[TBL] [Abstract][Full Text] [Related]
15. Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.
Marverti G; Marraccini C; Martello A; D'Arca D; Pacifico S; Guerrini R; Spyrakis F; Gozzi G; Lauriola A; Santucci M; Cannazza G; Tagliazucchi L; Cazzato AS; Losi L; Ferrari S; Ponterini G; Costi MP
J Med Chem; 2021 Mar; 64(6):3204-3221. PubMed ID: 33710891
[TBL] [Abstract][Full Text] [Related]
16. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
[TBL] [Abstract][Full Text] [Related]
18. The R163K mutant of human thymidylate synthase is stabilized in an active conformation: structural asymmetry and reactivity of cysteine 195.
Gibson LM; Lovelace LL; Lebioda L
Biochemistry; 2008 Apr; 47(16):4636-43. PubMed ID: 18370400
[TBL] [Abstract][Full Text] [Related]
19. The structural mechanism for half-the-sites reactivity in an enzyme, thymidylate synthase, involves a relay of changes between subunits.
Anderson AC; O'Neil RH; DeLano WL; Stroud RM
Biochemistry; 1999 Oct; 38(42):13829-36. PubMed ID: 10529228
[TBL] [Abstract][Full Text] [Related]
20. 2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives.
Ferrari S; Calò S; Leone R; Luciani R; Costantino L; Sammak S; Di Pisa F; Pozzi C; Mangani S; Costi MP
J Med Chem; 2013 Nov; 56(22):9356-60. PubMed ID: 24147825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
